The future of gene editing with Intellia’s CEO
- blonca9
- Jun 23, 2023
- 1 min read
Intellia Therapeutics CEO John Leonard on where he sees gene editing fitting into the practice of medicine.
Also look for unique social pages for BiotechTV U.
Allucent Clinical Research Organization™ is on a mission to help bring new therapies to light by solving the distinct challenges of small and mid-sized biotech companies. We’re a global provider of comprehensive drug development solutions, including consulting, clinical operations, biometrics, and clinical pharmacology across a variety of therapeutic areas.